Study shows stroke prevention clinics reduce one-year mortality rates by over 25 percent

Research led by Dr. Vladimir Hachinski of The University of Western Ontario reveals just how important it is for patients to be referred to a stroke prevention clinic following either a mild stroke or a transient ischemic attack (TIA). The study, published in the journal Stroke in November, showed a 26% reduction in one-year mortality rates among those referred to a stroke prevention clinic.

The risk of stroke after a TIA may be as high as 20% in the first three months. Half of the strokes occur in the first 24 to 48 hours after a TIA. Organized inpatient care has been shown to decrease morbidity and mortality but little research has been done on the benefits of organized outpatient clinics. These clinics facilitate early assessment, diagnosis and treatment of patients with a recent TIA or non-disabling stroke.

Using data from the Registry of the Canadian Stroke Network, the researchers compared more than 16,000 patients with or TIA seen in the emergency department or admitted to hospital in Ontario between July 1, 2003 and March 31, 2008.

"Organized works," says Dr. Hachinski, a Professor in the Department of Clinical Neurological Sciences at Western's Schulich School of Medicine & Dentistry, and a Scientist with the Lawson Health Research Institute. "It doesn't really matter about the size, location and hours of these clinics. Patients benefit because you have interested people with some expertise, following best practice standards and gaining experience from doing things repeatedly."

"This study provides important evidence that referral to a SPC reduces mortality. The basic underlying principle of our study is that organized care, even with staggered models, makes a positive difference at all levels," adds Fiona Webster, first author and Education Scientist/Assistant Professor in the Department of Family and Community Medicine at the University of Toronto.

Provided by University of Western Ontario

not rated yet
add to favorites email to friend print save as pdf

Related Stories

1 in 8 strokes is preceded by 'warning stroke'

Sep 28, 2009

One out of every eight strokes is preceded by a "warning stroke," which is a transient ischemic attack (TIA) or mild stroke, according to research published in the September 29, 2009, print issue of Neurology.

Women less likely to have a stroke after mini-stroke

Feb 23, 2009

30 days after a transient ischemic attack, women are 30 percent less likely to have a stroke than men, according to researchers at the University of Alabama at Birmingham (UAB) and Yale University. The analysis, including ...

Hundreds of strokes avoidable, says study

Nov 26, 2007

Hundreds of strokes could be prevented each year if patients suffering ‘mini strokes’, known as transient ischaemic attacks or TIAs, were assessed sooner by specialist clinicians.

Recommended for you

Timely treatment after stroke is crucial, researchers report

5 hours ago

For years, the mantra of neurologists treating stroke victims has been "time equals brain." That's because getting a patient to the emergency room quickly to receive a drug that dissolves the stroke-causing blood clot can ...

Laughing gas does not increase heart attacks

6 hours ago

(Medical Xpress)—Nitrous oxide—best known as laughing gas—is one of the world's oldest and most widely used anesthetics. Despite its popularity, however, experts have questioned its impact on the risk ...

User comments

More news stories

Validating maps of the brain's resting state

Kick back and shut your eyes. Now stop thinking. You have just put your brain into what neuroscientists call its resting state. What the brain is doing when an individual is not focused on the outside world ...

Antioxidant shows promise in Parkinson's disease

Diapocynin, a synthetic molecule derived from a naturally occurring compound (apocynin), has been found to protect neurobehavioral function in mice with Parkinson's Disease symptoms by preventing deficits in motor coordination.

No danger of cancer through gene therapy virus

In fall 2012, the European Medicines Agency (EMA) approved the modified adeno-associated virus AAV-LPL S447X as the first ever gene therapy for clinical use in the Western world. uniQure, a Dutch biotech company, had developed ...